Caleb Monroe

Caleb Monroe

Consumer & Retail Analyst

Consumer analyst covering e-commerce, retail, and branded consumer products. Former product manager with experience in pricing, demand forecasting, and retention analytics. Focuses on unit economics, cohort behavior, brand strength, and margin structure under different promotional environments.

Articles 786

Jan 11, 2026 Finance

From $2,000 to Billionaire: The Early Struggles and Ventures of Elon Musk

A detailed look at Musk’s journey from immigrant student to global business magnate

Elon Musk’s path to becoming a billionaire began with a modest $2,000 upon arriving in North America at 17. Self-financing his education, dropping o...

Sam Altman on Leading OpenAI as a Public Company: Reluctant Yet Realistic
Jan 11, 2026 Finance

Sam Altman on Leading OpenAI as a Public Company: Reluctant Yet Realistic

The OpenAI CEO expresses little enthusiasm for going public but acknowledges eventual necessity amid growth and capital demands

OpenAI CEO Sam Altman conveyed a marked lack of excitement about taking OpenAI public, describing the prospect as potentially "really annoying." In di...

Extreme Cold Halts Flights and Disrupts Travel in Finnish Lapland and Across Northern Europe
Jan 11, 2026 News & Politics

Extreme Cold Halts Flights and Disrupts Travel in Finnish Lapland and Across Northern Europe

Thousands of visitors stranded at Kittilä airport amid plummeting temperatures and widespread travel interruptions in Europe

Severe cold weather conditions have caused significant travel disruptions in northern Finland, leaving thousands of tourists stranded at Kittilä airp...

Jan 11, 2026 Trade Ideas

Meta Headlines Flip Oklo’s Risk Profile — Upgrade to Bullish (Trade Idea)

A short runway to a meaningful re-rating — use the Meta momentum, strong balance sheet and financing to play a defined-risk swing.

Oklo's share price has repriced higher after press reports tied the company to Meta's nuclear power push. The company is still pre-revenue but has mea...

Trade Idea Long
Jan 11, 2026 Finance

Top Large-Cap Stocks Surge Amid Defense Boosts, Industry Collaborations, and Merger Speculations

An Overview of Last Week's Significant Market Movers in Defense, Technology, and Energy Sectors

Last week witnessed a notable rally among large-cap stocks driven by heightened defense expenditure, significant AI infrastructure partnerships, and b...

Sanders Challenges 'America First' in Light of Trump’s Foreign Agreements
Jan 10, 2026 Business News

Sanders Challenges 'America First' in Light of Trump’s Foreign Agreements

Senator Bernie Sanders critiques the alignment of President Trump’s international policies with the proclaimed domestic priority

Senator Bernie Sanders has raised questions about the sincerity of President Donald Trump’s "America First" agenda, pointing to several foreign poli...

Nobel Institute Clarifies Prize Rules Amid Venezuelan Leader's Suggestion to Share Honor with Trump
Jan 10, 2026 Business News

Nobel Institute Clarifies Prize Rules Amid Venezuelan Leader's Suggestion to Share Honor with Trump

María Corina Machado's proposal to share the Peace Prize sparks official response reinforcing Nobel guidelines

The Norwegian Nobel Institute reaffirmed the finality and indivisibility of its Peace Prize following Venezuelan opposition figure María Corina Macha...

CMS Restricts Medicare Advantage Coverage for Common Cosmetic Procedures
Jan 10, 2026 Business News

CMS Restricts Medicare Advantage Coverage for Common Cosmetic Procedures

New 2026 Rule Bars Medicare Advantage Plans from Covering Various Cosmetic Surgeries Affecting Millions of Seniors

The Centers for Medicare and Medicaid Services (CMS) has introduced a regulation effective in 2026 that prohibits Medicare Advantage plans from coveri...

Preparing for Market Uncertainty: Strategic Steps Investors Should Consider Now
Jan 10, 2026 Business News

Preparing for Market Uncertainty: Strategic Steps Investors Should Consider Now

Assessing Indicators and Focusing on Quality Stocks to Navigate Potential Market Volatility

With 2025 marking an exceptional year for stock market growth, concerns about a possible downturn in 2026 have surfaced among investors. Although pred...

Jan 10, 2026 Trade Ideas

Buy Genmab (GMAB) on Strength of Recent Clinical Readouts — Buy on Pullback or Breakout

Clinical catalysts and corporate moves put Genmab back in growth mode; trade plan favors a risk-managed long.

Genmab's December 2025 clinical dataset (EPKINLY and epcoritamab programs) and aggressive corporate moves (Merus tender/offer activity and debt financ...

Trade Idea Long